About ProciseDx
ProciseDx is a company based in San Diego (United States) founded in 2018 was acquired by Biosynex in June 2023.. ProciseDx has raised $8.96 million across 3 funding rounds from investors including Nestlé Health Science and Biosynex. ProciseDx offers products and services including Drug Monitoring Assays and ProciseDx Platform. ProciseDx operates in a competitive market with competitors including EKF, LumiraDx, SpinChip, LightDeck Diagnostics and EDX Medical Group, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.96 M (USD)
in 3 rounds
-
Latest Funding Round
$13 M (USD), Debt – Convertible
Jul 13, 2021
-
Investors
Nestlé Health Science
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Biosynex
(Jun 12, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ProciseDx
ProciseDx offers a comprehensive portfolio of products and services, including Drug Monitoring Assays and ProciseDx Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provide quick, accurate drug level measurements from blood samples.
Enables immediate clinical decisions with quantitative immunoassays.
Funding Insights of ProciseDx
ProciseDx has successfully raised a total of $8.96M across 3 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $13 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Convertible — $13.0M
-
First Round
First Round
(21 Jul 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Debt – Convertible - ProciseDx | Valuation | Nestlé Health Science | |
| Jul, 2020 | Amount | Series A - ProciseDx | Valuation | Biosynex |
|
| Jul, 2020 | Amount | Debt – Conventional - ProciseDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ProciseDx
ProciseDx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nestlé Health Science and Biosynex. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nutritional dietary supplements are provided for health and wellness needs.
|
Founded Year | Domain | Location | |
|
Professional rapid diagnostic tests for diseases are manufactured by Biosynex.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProciseDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ProciseDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Procisedx Comparisons
Competitors of ProciseDx
ProciseDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, LumiraDx, SpinChip, LightDeck Diagnostics and EDX Medical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| domain | founded_year | HQ Location |
Cloud based diagnostics platform for point of care diagnosing
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| domain | founded_year | HQ Location |
Medical diagnostics solutions are researched by the laboratory.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Procisedx
Frequently Asked Questions about ProciseDx
When was ProciseDx founded?
ProciseDx was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is ProciseDx located?
ProciseDx is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of ProciseDx?
Larry Mimms is the current CEO of ProciseDx.
Is ProciseDx a funded company?
ProciseDx is a funded company, having raised a total of $8.96M across 3 funding rounds to date. The company's 1st funding round was a Series A of $8.96M, raised on Jul 21, 2020.
What does ProciseDx do?
ProciseDx was established in 2018 in San Diego, United States, within the healthcare diagnostics sector. A point-of-care device is supplied to professionals for clinical analysis. Proprietary Lumiphore technology is employed to measure patient samples, including blood, urine, and stool, in immunoassay procedures. Results from the device are used by healthcare providers to support diagnosis and treatment decisions in various settings.
Who are the top competitors of ProciseDx?
What products or services does ProciseDx offer?
ProciseDx offers Drug Monitoring Assays and ProciseDx Platform.
Who are ProciseDx's investors?
ProciseDx has 2 investors. Key investors include Nestlé Health Science, and Biosynex.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.